DE69825431D1 - Diagnostik zur früherkennung von magenkrebs - Google Patents

Diagnostik zur früherkennung von magenkrebs

Info

Publication number
DE69825431D1
DE69825431D1 DE69825431T DE69825431T DE69825431D1 DE 69825431 D1 DE69825431 D1 DE 69825431D1 DE 69825431 T DE69825431 T DE 69825431T DE 69825431 T DE69825431 T DE 69825431T DE 69825431 D1 DE69825431 D1 DE 69825431D1
Authority
DE
Germany
Prior art keywords
cox
diagnostics
stomach cancer
early detection
gastric cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69825431T
Other languages
English (en)
Other versions
DE69825431T2 (de
Inventor
Ari Ristimaeki
Matti Haerkoenen
Pentti Sipponen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohit Oy
Original Assignee
Biohit Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oy filed Critical Biohit Oy
Publication of DE69825431D1 publication Critical patent/DE69825431D1/de
Application granted granted Critical
Publication of DE69825431T2 publication Critical patent/DE69825431T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
DE69825431T 1997-03-18 1998-03-18 Diagnostik zur früherkennung von magenkrebs Expired - Lifetime DE69825431T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer
FI971124 1997-03-18
PCT/FI1998/000238 WO1998041864A1 (en) 1997-03-18 1998-03-18 Diagnosis of early gastric cancer

Publications (2)

Publication Number Publication Date
DE69825431D1 true DE69825431D1 (de) 2004-09-09
DE69825431T2 DE69825431T2 (de) 2005-07-28

Family

ID=8548414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69825431T Expired - Lifetime DE69825431T2 (de) 1997-03-18 1998-03-18 Diagnostik zur früherkennung von magenkrebs

Country Status (20)

Country Link
US (1) US6416961B1 (de)
EP (1) EP0968421B1 (de)
JP (1) JP2001519900A (de)
KR (1) KR20000076291A (de)
CN (1) CN1250523A (de)
AT (1) ATE272838T1 (de)
AU (1) AU732228B2 (de)
BR (1) BR9808378A (de)
CA (1) CA2284048A1 (de)
DE (1) DE69825431T2 (de)
DK (1) DK0968421T3 (de)
ES (1) ES2226105T3 (de)
FI (1) FI971124A0 (de)
IL (1) IL131594A (de)
NO (1) NO994440L (de)
NZ (1) NZ338068A (de)
PT (1) PT968421E (de)
RU (1) RU2204835C2 (de)
TR (1) TR199902298T2 (de)
WO (1) WO1998041864A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335193B1 (en) * 1999-04-15 2002-01-01 Padmanabhan P Nair Isolated colonocytes
AU2543301A (en) * 2000-01-14 2001-07-24 Vera Genics Ltd. Method and kit for diagnosis of neoplastic transformation
EP1268854A4 (de) 2000-03-27 2003-05-02 Univ Jefferson Markerdetektion mit hoher spezifität
WO2001075169A2 (en) * 2000-03-30 2001-10-11 Diadexus, Inc. Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
WO2003001183A2 (en) * 2001-06-25 2003-01-03 Oncomedx, Inc. Methods for detecting and monitoring cox-2 rna in plasma and serum
AU2002359817A1 (en) * 2001-12-21 2003-07-30 Diadexus, Inc. Compositions and methods relating to gastric specific genes and proteins
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
WO2004007770A2 (en) * 2002-07-10 2004-01-22 Oncotherapy Science, Inc. Method for diagnosis of intestinal-type gastric tumors
AU2003263607A1 (en) * 2002-10-25 2004-05-13 Japan As Represented By The President Of The University Of Tokyo Method for diagnosing diffuse-type gastric cancer
CN105316405A (zh) * 2003-07-17 2016-02-10 环太平洋生物技术有限公司 用于胃癌检测的标记物
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
KR100645979B1 (ko) * 2004-08-09 2006-11-15 한국생명공학연구원 위암 유전자 마커 및 이를 이용한 위암 진단킷트
US20080312093A1 (en) * 2005-11-04 2008-12-18 Johji Inazawa Method for detecting cancer and a method for suppressing cancer
RU2613139C1 (ru) * 2015-10-12 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ дифференциальной диагностики рака желудка различных гистологических типов
RU2613300C1 (ru) * 2015-11-10 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики низко дифференцированного нейроэндокринного рака желудка
RU2642989C1 (ru) * 2016-12-19 2018-01-29 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Способ диагностики онкологических заболеваний
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
RU2743221C1 (ru) * 2020-10-12 2021-02-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ определения типа рака желудка по классификации lauren методом компьютерной томографии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459239A (en) 1994-01-24 1995-10-17 Merck Frosst Canada Inc. Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins

Also Published As

Publication number Publication date
CA2284048A1 (en) 1998-09-24
KR20000076291A (ko) 2000-12-26
WO1998041864A1 (en) 1998-09-24
TR199902298T2 (xx) 2000-01-21
IL131594A (en) 2004-02-19
IL131594A0 (en) 2001-01-28
PT968421E (pt) 2004-10-29
AU732228B2 (en) 2001-04-12
ATE272838T1 (de) 2004-08-15
JP2001519900A (ja) 2001-10-23
NO994440D0 (no) 1999-09-13
DE69825431T2 (de) 2005-07-28
NZ338068A (en) 2001-03-30
NO994440L (no) 1999-11-18
US6416961B1 (en) 2002-07-09
AU6404198A (en) 1998-10-12
CN1250523A (zh) 2000-04-12
FI971124A0 (fi) 1997-03-18
EP0968421A1 (de) 2000-01-05
ES2226105T3 (es) 2005-03-16
EP0968421B1 (de) 2004-08-04
RU2204835C2 (ru) 2003-05-20
DK0968421T3 (da) 2004-12-06
BR9808378A (pt) 2000-05-23

Similar Documents

Publication Publication Date Title
DE69825431D1 (de) Diagnostik zur früherkennung von magenkrebs
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
ATE394658T1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
CA2072314A1 (en) Methods for detection of carcinoma metastases by nucleic acid amplification
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
ATE354588T1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
ATE435654T1 (de) Manipulierte proteine zum analyten nachweis
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
EP1318399A3 (de) Passive Probefeststellung zum Beginn einer Analyse
CA2318354A1 (en) Biomarkers and targets for diagnosis, prognosis and management of prostate disease
DK0667920T3 (da) Fremgangsmåder til påvisning af prostatacancermetastase
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
ES2082217T3 (es) Procedimiento de amplificacion de la señal de emision de un compuesto luminiscente.
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE384952T1 (de) Enzymhemmungsimmunverfahren
DE60223149D1 (de) Nachweisverfahren mit biochip
DK0958500T3 (da) Immunohistokemisk påvisningsassay for carcinomproliferationsstatus
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
WO2001002828A3 (en) Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
WO2004002294B1 (en) Plasma or serum marker and process for detection of cancer
ATE209691T1 (de) Primer und sonden zur amplifizierung und zum nachweis von cmv nukleinsäure
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
Yu et al. SOX-17 Gene Sequence Complementation on Silica-alumina Nanocomposite-modified Dielectrode Surface for Analyzing Gastric Cancer Progression
DE60126088D1 (de) Wechselwirkung zwischen tbx2 und dem arf-promoter in zellzyklus-regulator-assays

Legal Events

Date Code Title Description
8364 No opposition during term of opposition